Phase I Study~to determine and compare the safety of single ascending doses of POL6326 by intravenous infusion~to determine the relationship between 2-hour single intravenous infusion doses of POL6326 and the concentration of HSC and mature WBC in peripheral blood using immunophenotypic assays.
Phase I study to determine and compare the safety/tolerability of single ascending doses of POL6326 by intravenous infusion.